title: Genomic and genetic characterization of cholangiocarcinoma identifies therapeutics targets for tyrosine kinase inhibitors.
authors.forename: Giovanni
authors.initials: G
authors.lastname: Brandi
authors.forename: Simona
authors.initials: S
authors.lastname: Tavolari
authors.forename: Guido
authors.initials: G
authors.lastname: Biasco
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology*; D001650:Bile Duct Neoplasms / Q000235:genetics*; D001653:Bile Ducts, Intrahepatic; D018281:Cholangiocarcinoma / Q000235:genetics*; D005260:Female; D006801:Humans; D008297:Male; D047428:Protein Kinase Inhibitors / Q000494:pharmacology*; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors* / Q000235:genetics*
chemical_list: D000970:Antineoplastic Agents; D047428:Protein Kinase Inhibitors; D011505:Protein-Tyrosine Kinases